Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Exploratory Clinical Trial of Daridorexant in Idiopathic and Parkinson's Disease-Related REM Sleep Behavior Disorder: A Multimodal Efficacy and Mechanism Study (China)

China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Double-Blind, Placebo-Controlled Exploratory Clinical Trial of Daridorexant in Idiopathic and Parkinson's Disease-Related REM Sleep Behavior Disorder: A Multimodal Efficacy and Mechanism Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133902

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346302

Published by HT Digital Content Services with permission from Health Daily Di...